SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-034023
Filing Date
2023-12-08
Accepted
2023-12-08 17:04:56
Documents
1
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1326
  Complete submission text file 0001437749-23-034023.txt   2811
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142
Business Address
Nicaise Claude (Reporting) CIK: 0001644162 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29959 | Film No.: 231476244